Compare Cerus Corporation vs Stratec
Customers evaluate the quality of Cerus Corporation's products using the following success metrics.
Overview
Cerus Corporation is 33 yrs old and is based in United States.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is currently in clinical development.
Stratec is 45 yrs old and is based in Germany.
Stratec develops automation solutions for in-vitro diagnostics and life science companies. Additionally, the firm provides advisory services to laboratories and healthcare facilities.
Demo Video
Leadership
Arnaud Besnard (Managing Director)
Ralf Griebel (Senior Vice President)
Investors
LRG Capital Group, Galleon Management
Synthes, Northwestern Mutual Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cerus Corporation has not claimed their profile.
Work for Cerus Corporation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cerus Corporation?
Claim your profile now.
Information not available because Stratec has not claimed their profile.
Work for Stratec? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Stratec?
Claim your profile now.